Vol 68, No 12 (2010)
Letters to the Editor
Published online: 2010-12-20
The use of a novel type of distal protection system (FiberNet®) in the percutaneous management of saphenous vein graft disease
DOI: 10.33963/v.kp.79893
Kardiol Pol 2010;68(12):1423-1425.
Abstract
Percutaneous intervention in saphenous vein grafts is associated with a high risk of distal embolisation by plaque material, ‘no
flow’ phenomenon and clinical complications such as myocardial infarction or death. According to randomised trial evidence,
intervention in a degenerated vein graft should be performed using an embolic protection device (EPD), since this
strategy significantly reduces periprocedural and 30 day adverse event rate. FiberNet® is a novel distal protection system with
unique characteristics of a low crossing profile (0.031’’ for vessel size 3.5-5 mm), ‘cotton wool’-like three dimensional design
and a small pore size (40 μm). The FiberNet® does not require a separate delivery sheath and self-achieves its optimal
apposition to the vessel wall; the EPD system also contains a dedicated aspiration catheter. We present the use of FiberNet®
in a 77 year-old patient who had undergone coronary artery bypass grafting 20 years ago and currently presented with CCS
class III angina due to a significant stenosis of the saphenous vein graft to the marginal branch. The procedure involved the
use of a novel mesh-covered stent (MGuard®) designed to ‘trap’ the plaque material between the stent and the vessel wall.
It was technically successful and clinically uncomplicated, and the patient remains well six months later.
Kardiol Pol 2010; 68, 12: 1423-1425
Kardiol Pol 2010; 68, 12: 1423-1425
Keywords: saphenous vein graft diseaseembolic protection devicesmesh-covered stent